Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAvenir is a prominent Israeli life sciences company that specializes in the distribution and representation of international biotechnology and diagnostic manufacturers. Established in 1995, the company serves as a critical bridge for global firms seeking to enter the Israeli market, providing comprehensive sales, marketing, and technical support. Their portfolio encompasses a wide range of high-quality products, including molecular biology reagents, clinical diagnostic kits, and advanced medical devices. BioAvenir caters to a diverse clientele that includes academic research institutions, major hospitals, and private biotechnology companies throughout Israel. The company is recognized for its technical expertise and its role in facilitating the adoption of cutting-edge research tools in the local scientific community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAvenir.